HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antonino Carlo Privitera Selected Research
Antonino Carlo Privitera Research Topics
Disease
8
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 05/2017
5
Crohn Disease (Crohn's Disease)
01/2022 - 01/2020
4
Ulcerative Colitis
01/2021 - 12/2018
2
COVID-19
04/2022 - 12/2020
1
Pneumonia (Pneumonitis)
04/2022
1
Spondylarthropathies
11/2020
1
Necrosis
01/2020
1
Hernia (Hernias)
01/2009
1
Rectocele
07/2008
Drug/Important Bio-Agent (IBA)
4
vedolizumab
IBA
01/2022 - 01/2018
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2022 - 01/2020
3
Adalimumab (Humira)
FDA Link
11/2021 - 12/2018
2
Biosimilar Pharmaceuticals
IBA
11/2021 - 01/2021
2
Infliximab (Remicade)
FDA Link
01/2021 - 05/2017
2
golimumab
FDA Link
01/2020 - 12/2018
1
Immunomodulating Agents
IBA
04/2022
1
Steroids
IBA
04/2022
1
ABP 501
IBA
11/2021
1
CT-P13
IBA
01/2021
1
Ustekinumab (CNTO 1275)
FDA Link
11/2020
1
Monoclonal Antibodies
IBA
01/2020
1
Polypropylenes (Polypropylene)
IBA
01/2009
1
parietex
IBA
01/2009
Therapy/Procedure
3
Therapeutics
12/2020 - 07/2008
1
Psychology Biofeedback (Biofeedback)
07/2008